Stents should be used routinely when percutaneous coronary intervention (PCI) is the clinically appropriate procedure for people with stable angina.
For recommendations on drug-eluting stents for people with unstable angina, non-ST-segment-elevation myocardial infarction (NSTEMI) or ST-segment-elevation myocardial infarction (STEMI), see recommendation 1.1.18 and recommendation 1.2.18 in NICE's guideline on acute coronary syndromes. [2020]
This recommendation has been replaced by NICE's technology appraisal guidance on drug-eluting stents for the treatment of coronary artery disease. [2008]
This recommendation has been replaced by NICE's technology appraisal guidance on drug-eluting stents for the treatment of coronary artery disease. [2008]
This recommendation has been replaced by NICE's technology appraisal guidance on drug-eluting stents for the treatment of coronary artery disease. [2008]
This guidance specifically relates to the present clinical indications for PCI and excludes conditions (such as many cases of stable angina) that are adequately managed with standard drug therapy. [2003]